| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2006-08-13 08:03:49 UTC |
|---|
| Update Date | 2022-03-07 02:49:20 UTC |
|---|
| HMDB ID | HMDB0003956 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 7a-Hydroxytestosterone |
|---|
| Description | 4-Hydroxytestosterone is the 17-hydroxylated analog to formestane. It is commercially available on the internet as anabolic steroid for oral self-administration and does not have any therapeutic indication. Hence, only little information is available about its metabolism. So far, most studies dealt with 4-hydroxytestosterone as metabolite of formestane while one study investigated the glucuronic acid conjugates of metabolic products of 4-hydroxytestosterone. This substance is prohibited in sports by the World Anti-Doping Agency; there is to a considerable increase of structurally related steroids with anabolic effects offered via the internet. 4-Hydroxytestosterone is a metabolite of the steroidal aromatase inhibitor 4-hydroxyandrost-4-ene-3,17-dione (4OHA). (PMID: 17724580 , 17610244 , 17207827 , 1284430 ). |
|---|
| Structure | C[C@]12CCC3C(CCC4=C(O)C(=O)CC[C@]34C)C1CC[C@@H]2O InChI=1S/C19H28O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,16,21-22H,3-10H2,1-2H3/t11?,12?,13?,16-,18+,19-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (17beta)-4,17-Dihydroxy-androst-4-en-3-one | HMDB | | (3b,17a)-Androst-5-ene-3,17-diol | HMDB | | 3b,17a-Dihydroxyandrost-5-ene | HMDB | | 4,17beta-Dihydroxy-4-androstene-3-one | HMDB | | 4-Androstene-7alpha-17beta-diol-3-one | HMDB | | 4-OHT | HMDB | | 7alpha-Hydroxytestosterone | HMDB | | Androst-5-ene-3b,17a-diol | HMDB | | D5-Androstene-3b,17a-diol | HMDB | | 4,17 beta-Dihydroxy-4-androstene-3-one | MeSH, HMDB |
|
|---|
| Chemical Formula | C19H28O3 |
|---|
| Average Molecular Weight | 304.4238 |
|---|
| Monoisotopic Molecular Weight | 304.203844762 |
|---|
| IUPAC Name | (2R,14S,15S)-6,14-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one |
|---|
| Traditional Name | (2R,14S,15S)-6,14-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one |
|---|
| CAS Registry Number | 2141-17-5 |
|---|
| SMILES | C[C@]12CCC3C(CCC4=C(O)C(=O)CC[C@]34C)C1CC[C@@H]2O |
|---|
| InChI Identifier | InChI=1S/C19H28O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,16,21-22H,3-10H2,1-2H3/t11?,12?,13?,16-,18+,19-/m0/s1 |
|---|
| InChI Key | BQOIJSIMMIDHMO-XRJYYLNASA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as androgens and derivatives. These are 3-hydroxylated C19 steroid hormones. They are known to favor the development of masculine characteristics. They also show profound effects on scalp and body hair in humans. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Androstane steroids |
|---|
| Direct Parent | Androgens and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Androgen-skeleton
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- 4-hydroxysteroid
- Hydroxysteroid
- Oxosteroid
- 17-hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Cyclic alcohol
- Ketone
- Secondary alcohol
- Cyclic ketone
- Enol
- Organic oxygen compound
- Organooxygen compound
- Alcohol
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 155 - 156 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | 2.344 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.37 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.8279 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.37 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2398.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 250.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 180.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 169.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 404.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 605.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 578.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 111.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1007.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 426.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1408.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 314.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 420.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 313.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 308.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 83.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 7a-Hydroxytestosterone,1TMS,isomer #1 | C[C@]12CCC3C(CCC4=C(O[Si](C)(C)C)C(=O)CC[C@@]43C)C1CC[C@@H]2O | 2831.8 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,1TMS,isomer #2 | C[C@]12CCC3C(CCC4=C(O)C(=O)CC[C@@]43C)C1CC[C@@H]2O[Si](C)(C)C | 2783.5 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,1TMS,isomer #3 | C[C@]12CCC3C(CCC4=C(O)C(O[Si](C)(C)C)=CC[C@@]43C)C1CC[C@@H]2O | 2771.9 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,2TMS,isomer #1 | C[C@]12CCC3C(CCC4=C(O[Si](C)(C)C)C(=O)CC[C@@]43C)C1CC[C@@H]2O[Si](C)(C)C | 2876.4 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,2TMS,isomer #2 | C[C@]12CCC3C(CCC4=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=CC[C@@]43C)C1CC[C@@H]2O | 2812.8 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,2TMS,isomer #3 | C[C@]12CCC3C(CCC4=C(O)C(O[Si](C)(C)C)=CC[C@@]43C)C1CC[C@@H]2O[Si](C)(C)C | 2815.7 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,3TMS,isomer #1 | C[C@]12CCC3C(CCC4=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=CC[C@@]43C)C1CC[C@@H]2O[Si](C)(C)C | 2822.3 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,3TMS,isomer #1 | C[C@]12CCC3C(CCC4=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=CC[C@@]43C)C1CC[C@@H]2O[Si](C)(C)C | 2847.1 | Standard non polar | 33892256 | | 7a-Hydroxytestosterone,3TMS,isomer #1 | C[C@]12CCC3C(CCC4=C(O[Si](C)(C)C)C(O[Si](C)(C)C)=CC[C@@]43C)C1CC[C@@H]2O[Si](C)(C)C | 3051.4 | Standard polar | 33892256 | | 7a-Hydroxytestosterone,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=C2CCC3C4CC[C@H](O)[C@@]4(C)CCC3[C@@]2(C)CCC1=O | 3070.6 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@H]1CCC2C3CCC4=C(O)C(=O)CC[C@]4(C)C3CC[C@@]21C | 3037.3 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O)CCC1C3CC[C@H](O)[C@@]3(C)CCC12 | 3035.9 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=C2CCC3C4CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]4(C)CCC3[C@@]2(C)CCC1=O | 3336.0 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O[Si](C)(C)C(C)(C)C)CCC1C3CC[C@H](O)[C@@]3(C)CCC12 | 3270.0 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O)CCC1C3CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]3(C)CCC12 | 3296.6 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O[Si](C)(C)C(C)(C)C)CCC1C3CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]3(C)CCC12 | 3498.6 | Semi standard non polar | 33892256 | | 7a-Hydroxytestosterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O[Si](C)(C)C(C)(C)C)CCC1C3CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]3(C)CCC12 | 3313.7 | Standard non polar | 33892256 | | 7a-Hydroxytestosterone,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC[C@@]2(C)C(=C1O[Si](C)(C)C(C)(C)C)CCC1C3CC[C@H](O[Si](C)(C)C(C)(C)C)[C@@]3(C)CCC12 | 3365.6 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 7a-Hydroxytestosterone GC-MS (Non-derivatized) - 70eV, Positive | splash10-004j-0090000000-f8c70e9c073ebf34b059 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 7a-Hydroxytestosterone GC-MS (2 TMS) - 70eV, Positive | splash10-001i-1022900000-600be045d8943f743d57 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 7a-Hydroxytestosterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 7a-Hydroxytestosterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 10V, Positive-QTOF | splash10-052r-0095000000-1ed1d6e3a92671fd2ad0 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 20V, Positive-QTOF | splash10-0a70-0391000000-688b70f5d7af33f8cee6 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 40V, Positive-QTOF | splash10-0041-6690000000-280160a24bfda119b38c | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 10V, Negative-QTOF | splash10-0udi-0029000000-e348bdb79d40a4c67d8a | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 20V, Negative-QTOF | splash10-0udi-0069000000-414113628118ffc4436d | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 40V, Negative-QTOF | splash10-059i-1090000000-78462554e3a1a05a840c | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 10V, Negative-QTOF | splash10-0udi-0009000000-93986d59045cc7fce551 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 20V, Negative-QTOF | splash10-0udi-0019000000-92df155d883a35606e36 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 40V, Negative-QTOF | splash10-0udi-0095000000-c78824a01c7b942a579a | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 10V, Positive-QTOF | splash10-0a4r-0049000000-dee580cc76c7cfcdaec8 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 20V, Positive-QTOF | splash10-05n0-0590000000-4682faf86ab20fed64d6 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 7a-Hydroxytestosterone 40V, Positive-QTOF | splash10-0007-4910000000-82ee78b7109f9f4b5333 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Georgakopoulos CG, Vonaparti A, Stamou M, Kiousi P, Lyris E, Angelis YS, Tsoupras G, Wuest B, Nielen MW, Panderi I, Koupparis M: Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Commun Mass Spectrom. 2007;21(15):2439-46. [PubMed:17610244 ]
- Pozo OJ, Van Eenoo P, Deventer K, Delbeke FT: Development and validation of a qualitative screening method for the detection of exogenous anabolic steroids in urine by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2007 Oct;389(4):1209-24. Epub 2007 Aug 28. [PubMed:17724580 ]
- Kohler M, Parr MK, Opfermann G, Thevis M, Schlorer N, Marner FJ, Schanzer W: Metabolism of 4-hydroxyandrostenedione and 4-hydroxytestosterone: Mass spectrometric identification of urinary metabolites. Steroids. 2007 Mar;72(3):278-86. Epub 2007 Jan 17. [PubMed:17207827 ]
- Davies JH, Shearer RJ, Rowlands MG, Poon GK, Houghton J, Jarman M, Dowsett M: Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptor. J Enzyme Inhib. 1992;6(2):141-7. [PubMed:1284430 ]
|
|---|